Seta Clinic

Seta Clinic is a prominent Japanese medical institution specializing in autologous immune cell therapies for the treatment of various cancers. Founded in 1999, it was a pioneer in providing dendritic cell vaccine therapy and other advanced immunotherapies in a clinical setting. The clinic offers a comprehensive suite of treatments, including alpha-beta T cell therapy, gamma-delta T cell therapy, and cytotoxic T lymphocyte therapy, often used in conjunction with conventional treatments. Operating under the Medical Corporation Shinkokai, the Seta Clinic Group maintains several facilities across Japan, including locations in Tokyo, Osaka, and Fukuoka. The institution is recognized for its extensive clinical experience, having treated over 20,000 patients, and its ongoing collaborations with academic institutions to refine cell-based oncology treatments. Their approach focuses on personalized medicine, utilizing the patient's own immune cells to target specific cancer antigens.